"<!DOCTYPE html>\n<html lang=\"en-US\">\n<head>\n\t<meta charset=\"UTF-8\">\n\t<meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\" />\n\n<meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1' />\n\n\t<!-- This site is optimized with the Yoast SEO plugin v20.5 - https://yoast.com/wordpress/plugins/seo/ -->\n\t<title>Topic 1.1. Clinical Features of Friedreich ataxia - Clinical Management Guidelines for Friedreich Ataxia</title>\n\t<link rel=\"canonical\" href=\"https://frdaguidelines.org/1-1/\" />\n\t<meta property=\"og:locale\" content=\"en_US\" />\n\t<meta property=\"og:type\" content=\"article\" />\n\t<meta property=\"og:title\" content=\"Topic 1.1. Clinical Features of Friedreich ataxia - Clinical Management Guidelines for Friedreich Ataxia\" />\n\t<meta property=\"og:url\" content=\"https://frdaguidelines.org/1-1/\" />\n\t<meta property=\"og:site_name\" content=\"Clinical Management Guidelines for Friedreich Ataxia\" />\n\t<meta property=\"article:modified_time\" content=\"2022-10-24T19:39:56+00:00\" />\n\t<meta name=\"twitter:card\" content=\"summary_large_image\" />\n\t<meta name=\"twitter:label1\" content=\"Est. reading time\" />\n\t<meta name=\"twitter:data1\" content=\"17 minutes\" />\n\t<script type=\"application/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https://schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https://frdaguidelines.org/1-1/\",\"url\":\"https://frdaguidelines.org/1-1/\",\"name\":\"Topic 1.1. Clinical Features of Friedreich ataxia - Clinical Management Guidelines for Friedreich Ataxia\",\"isPartOf\":{\"@id\":\"https://frdaguidelines.org/#website\"},\"datePublished\":\"2022-06-10T16:46:14+00:00\",\"dateModified\":\"2022-10-24T19:39:56+00:00\",\"breadcrumb\":{\"@id\":\"https://frdaguidelines.org/1-1/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https://frdaguidelines.org/1-1/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https://frdaguidelines.org/1-1/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https://frdaguidelines.org/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Topic 1.1. Clinical Features of Friedreich ataxia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https://frdaguidelines.org/#website\",\"url\":\"https://frdaguidelines.org/\",\"name\":\"Clinical Management Guidelines for Friedreich Ataxia\",\"description\":\"Clinical Management Guidelines for Friedreich Ataxia\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https://frdaguidelines.org/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}</script>\n\t<!-- / Yoast SEO plugin. -->\n\n\n<link rel='dns-prefetch' href='//fonts.googleapis.com' />\n<link rel=\"alternate\" type=\"application/rss+xml\" title=\"Clinical Management Guidelines for Friedreich Ataxia &raquo; Feed\" href=\"https://frdaguidelines.org/feed/\" />\n<link rel=\"alternate\" type=\"application/rss+xml\" title=\"Clinical Management Guidelines for Friedreich Ataxia &raquo; Comments Feed\" href=\"https://frdaguidelines.org/comments/feed/\" />\n<script type=\"text/javascript\">\n/* <![CDATA[ */\nwindow._wpemojiSettings = {\"baseUrl\":\"https:\\/\\/s.w.org\\/images\\/core\\/emoji\\/14.0.0\\/72x72\\/\",\"ext\":\".png\",\"svgUrl\":\"https:\\/\\/s.w.org\\/images\\/core\\/emoji\\/14.0.0\\/svg\\/\",\"svgExt\":\".svg\",\"source\":{\"concatemoji\":\"https:\\/\\/frdaguidelines.org\\/wp-includes\\/js\\/wp-emoji-release.min.js?ver=6.4.1\"}};\n/*! This file is auto-generated */\n!function(i,n){var o,s,e;function c(e){try{var t={supportTests:e,timestamp:(new Date).valueOf()};sessionStorage.setItem(o,JSON.stringify(t))}catch(e){}}function p(e,t,n){e.clearRect(0,0,e.canvas.width,e.canvas.height),e.fillText(t,0,0);var t=new Uint32Array(e.getImageData(0,0,e.canvas.width,e.canvas.height).data),r=(e.clearRect(0,0,e.canvas.width,e.canvas.height),e.fillText(n,0,0),new Uint32Array(e.getImageData(0,0,e.canvas.width,e.canvas.height).data));return t.every(function(e,t){return e===r[t]})}function u(e,t,n){switch(t){case\"flag\":return n(e,\"\\ud83c\\udff3\\ufe0f\\u200d\\u26a7\\ufe0f\",\"\\ud83c\\udff3\\ufe0f\\u200b\\u26a7\\ufe0f\")?!1:!n(e,\"\\ud83c\\uddfa\\ud83c\\uddf3\",\"\\ud83c\\uddfa\\u200b\\ud83c\\uddf3\")&&!n(e,\"\\ud83c\\udff4\\udb40\\udc67\\udb40\\udc62\\udb40\\udc65\\udb40\\udc6e\\udb40\\udc67\\udb40\\udc7f\",\"\\ud83c\\udff4\\u200b\\udb40\\udc67\\u200b\\udb40\\udc62\\u200b\\udb40\\udc65\\u200b\\udb40\\udc6e\\u200b\\udb40\\udc67\\u200b\\udb40\\udc7f\");case\"emoji\":return!n(e,\"\\ud83e\\udef1\\ud83c\\udffb\\u200d\\ud83e\\udef2\\ud83c\\udfff\",\"\\ud83e\\udef1\\ud83c\\udffb\\u200b\\ud83e\\udef2\\ud83c\\udfff\")}return!1}function f(e,t,n){var r=\"undefined\"!=typeof WorkerGlobalScope&&self instanceof WorkerGlobalScope?new OffscreenCanvas(300,150):i.createElement(\"canvas\"),a=r.getContext(\"2d\",{willReadFrequently:!0}),o=(a.textBaseline=\"top\",a.font=\"600 32px Arial\",{});return e.forEach(function(e){o[e]=t(a,e,n)}),o}function t(e){var t=i.createElement(\"script\");t.src=e,t.defer=!0,i.head.appendChild(t)}\"undefined\"!=typeof Promise&&(o=\"wpEmojiSettingsSupports\",s=[\"flag\",\"emoji\"],n.supports={everything:!0,everythingExceptFlag:!0},e=new Promise(function(e){i.addEventListener(\"DOMContentLoaded\",e,{once:!0})}),new Promise(function(t){var n=function(){try{var e=JSON.parse(sessionStorage.getItem(o));if(\"object\"==typeof e&&\"number\"==typeof e.timestamp&&(new Date).valueOf()<e.timestamp+604800&&\"object\"==typeof e.supportTests)return e.supportTests}catch(e){}return null}();if(!n){if(\"undefined\"!=typeof Worker&&\"undefined\"!=typeof OffscreenCanvas&&\"undefined\"!=typeof URL&&URL.createObjectURL&&\"undefined\"!=typeof Blob)try{var e=\"postMessage(\"+f.toString()+\"(\"+[JSON.stringify(s),u.toString(),p.toString()].join(\",\")+\"));\",r=new Blob([e],{type:\"text/javascript\"}),a=new Worker(URL.createObjectURL(r),{name:\"wpTestEmojiSupports\"});return void(a.onmessage=function(e){c(n=e.data),a.terminate(),t(n)})}catch(e){}c(n=f(s,u,p))}t(n)}).then(function(e){for(var t in e)n.supports[t]=e[t],n.supports.everything=n.supports.everything&&n.supports[t],\"flag\"!==t&&(n.supports.everythingExceptFlag=n.supports.everythingExceptFlag&&n.supports[t]);n.supports.everythingExceptFlag=n.supports.everythingExceptFlag&&!n.supports.flag,n.DOMReady=!1,n.readyCallback=function(){n.DOMReady=!0}}).then(function(){return e}).then(function(){var e;n.supports.everything||(n.readyCallback(),(e=n.source||{}).concatemoji?t(e.concatemoji):e.wpemoji&&e.twemoji&&(t(e.twemoji),t(e.wpemoji)))}))}((window,document),window._wpemojiSettings);\n/* ]]> */\n</script>\n<style id='wp-emoji-styles-inline-css' type='text/css'>\n\n\timg.wp-smiley, img.emoji {\n\t\tdisplay: inline !important;\n\t\tborder: none !important;\n\t\tbox-shadow: none !important;\n\t\theight: 1em !important;\n\t\twidth: 1em !important;\n\t\tmargin: 0 0.07em !important;\n\t\tvertical-align: -0.1em !important;\n\t\tbackground: none !important;\n\t\tpadding: 0 !important;\n\t}\n</style>\n<link rel='stylesheet' id='wp-block-library-css' href='https://frdaguidelines.org/wp-includes/css/dist/block-library/style.min.css?ver=6.4.1' type='text/css' media='all' />\n<style id='classic-theme-styles-inline-css' type='text/css'>\n/*! This file is auto-generated */\n.wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none}\n</style>\n<style id='global-styles-inline-css' type='text/css'>\nbody{--wp--preset--color--black: #000000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #ffffff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;--wp--preset--spacing--20: 0.44rem;--wp--preset--spacing--30: 0.67rem;--wp--preset--spacing--40: 1rem;--wp--preset--spacing--50: 1.5rem;--wp--preset--spacing--60: 2.25rem;--wp--preset--spacing--70: 3.38rem;--wp--preset--spacing--80: 5.06rem;--wp--preset--shadow--natural: 6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep: 12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp: 6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined: 6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp: 6px 6px 0px rgba(0, 0, 0, 1);}:where(.is-layout-flex){gap: 0.5em;}:where(.is-layout-grid){gap: 0.5em;}body .is-layout-flow > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}body .is-layout-flow > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}body .is-layout-flow > .aligncenter{margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}body .is-layout-constrained > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}body .is-layout-constrained > .aligncenter{margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > :where(:not(.alignleft):not(.alignright):not(.alignfull)){max-width: var(--wp--style--global--content-size);margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > .alignwide{max-width: var(--wp--style--global--wide-size);}body .is-layout-flex{display: flex;}body .is-layout-flex{flex-wrap: wrap;align-items: center;}body .is-layout-flex > *{margin: 0;}body .is-layout-grid{display: grid;}body .is-layout-grid > *{margin: 0;}:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;}\n.wp-block-navigation a:where(:not(.wp-element-button)){color: inherit;}\n:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}\n:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}\n.wp-block-pullquote{font-size: 1.5em;line-height: 1.6;}\n</style>\n<link rel='stylesheet' id='theme.css-css' href='https://frdaguidelines.org/wp-content/plugins/popup-builder/public/css/theme.css?ver=4.1.14' type='text/css' media='all' />\n<link rel='stylesheet' id='parent-style-css' href='https://frdaguidelines.org/wp-content/themes/ashe/style.css?ver=6.4.1' type='text/css' media='all' />\n<link rel='stylesheet' id='child-theme-css-name-css' href='https://frdaguidelines.org/wp-content/themes/ashe-child/style.css?ver=1.0.1' type='text/css' media='all' />\n<link rel='stylesheet' id='ashe-style-css' href='https://frdaguidelines.org/wp-content/themes/ashe-child/style.css?ver=1.9.7' type='text/css' media='all' />\n<link rel='stylesheet' id='fontawesome-css' href='https://frdaguidelines.org/wp-content/themes/ashe/assets/css/font-awesome.css?ver=6.4.1' type='text/css' media='all' />\n<link rel='stylesheet' id='fontello-css' href='https://frdaguidelines.org/wp-content/themes/ashe/assets/css/fontello.css?ver=6.4.1' type='text/css' media='all' />\n<link rel='stylesheet' id='slick-css' href='https://frdaguidelines.org/wp-content/themes/ashe/assets/css/slick.css?ver=6.4.1' type='text/css' media='all' />\n<link rel='stylesheet' id='scrollbar-css' href='https://frdaguidelines.org/wp-content/themes/ashe/assets/css/perfect-scrollbar.css?ver=6.4.1' type='text/css' media='all' />\n<link rel='stylesheet' id='ashe-responsive-css' href='https://frdaguidelines.org/wp-content/themes/ashe/assets/css/responsive.css?ver=1.9.7' type='text/css' media='all' />\n<link rel='stylesheet' id='ashe-playfair-font-css' href='//fonts.googleapis.com/css?family=Playfair+Display%3A400%2C700&#038;ver=1.0.0' type='text/css' media='all' />\n<link rel='stylesheet' id='ashe-opensans-font-css' href='//fonts.googleapis.com/css?family=Open+Sans%3A400italic%2C400%2C600italic%2C600%2C700italic%2C700&#038;ver=1.0.0' type='text/css' media='all' />\n<script type=\"text/javascript\" src=\"https://frdaguidelines.org/wp-includes/js/jquery/jquery.min.js?ver=3.7.1\" id=\"jquery-core-js\"></script>\n<script type=\"text/javascript\" src=\"https://frdaguidelines.org/wp-includes/js/jquery/jquery-migrate.min.js?ver=3.4.1\" id=\"jquery-migrate-js\"></script>\n<script type=\"text/javascript\" id=\"Popup.js-js-before\">\n/* <![CDATA[ */\nvar sgpbPublicUrl = \"https:\\/\\/frdaguidelines.org\\/wp-content\\/plugins\\/popup-builder\\/public\\/\";\nvar SGPB_JS_LOCALIZATION = {\"imageSupportAlertMessage\":\"Only image files supported\",\"pdfSupportAlertMessage\":\"Only pdf files supported\",\"areYouSure\":\"Are you sure?\",\"addButtonSpinner\":\"L\",\"audioSupportAlertMessage\":\"Only audio files supported (e.g.: mp3, wav, m4a, ogg)\",\"publishPopupBeforeElementor\":\"Please, publish the popup before starting to use Elementor with it!\",\"publishPopupBeforeDivi\":\"Please, publish the popup before starting to use Divi Builder with it!\",\"closeButtonAltText\":\"Close\"};\n/* ]]> */\n</script>\n<script type=\"text/javascript\" src=\"https://frdaguidelines.org/wp-content/plugins/popup-builder/public/js/Popup.js?ver=4.1.14\" id=\"Popup.js-js\"></script>\n<script type=\"text/javascript\" src=\"https://frdaguidelines.org/wp-content/plugins/popup-builder/public/js/PopupConfig.js?ver=4.1.14\" id=\"PopupConfig.js-js\"></script>\n<script type=\"text/javascript\" id=\"PopupBuilder.js-js-before\">\n/* <![CDATA[ */\nvar SGPB_POPUP_PARAMS = {\"popupTypeAgeRestriction\":\"ageRestriction\",\"defaultThemeImages\":{\"1\":\"https:\\/\\/frdaguidelines.org\\/wp-content\\/plugins\\/popup-builder\\/public\\/img\\/theme_1\\/close.png\",\"2\":\"https:\\/\\/frdaguidelines.org\\/wp-content\\/plugins\\/popup-builder\\/public\\/img\\/theme_2\\/close.png\",\"3\":\"https:\\/\\/frdaguidelines.org\\/wp-content\\/plugins\\/popup-builder\\/public\\/img\\/theme_3\\/close.png\",\"5\":\"https:\\/\\/frdaguidelines.org\\/wp-content\\/plugins\\/popup-builder\\/public\\/img\\/theme_5\\/close.png\",\"6\":\"https:\\/\\/frdaguidelines.org\\/wp-content\\/plugins\\/popup-builder\\/public\\/img\\/theme_6\\/close.png\"},\"homePageUrl\":\"https:\\/\\/frdaguidelines.org\\/\",\"isPreview\":false,\"convertedIdsReverse\":[],\"dontShowPopupExpireTime\":365,\"conditionalJsClasses\":[],\"disableAnalyticsGeneral\":\"0\"};\nvar SGPB_JS_PACKAGES = {\"packages\":{\"current\":1,\"free\":1,\"silver\":2,\"gold\":3,\"platinum\":4},\"extensions\":{\"geo-targeting\":false,\"advanced-closing\":false}};\nvar SGPB_JS_PARAMS = {\"ajaxUrl\":\"https:\\/\\/frdaguidelines.org\\/wp-admin\\/admin-ajax.php\",\"nonce\":\"c7593ce132\"};\n/* ]]> */\n</script>\n<script type=\"text/javascript\" src=\"https://frdaguidelines.org/wp-content/plugins/popup-builder/public/js/PopupBuilder.js?ver=4.1.14\" id=\"PopupBuilder.js-js\"></script>\n<link rel=\"https://api.w.org/\" href=\"https://frdaguidelines.org/wp-json/\" /><link rel=\"alternate\" type=\"application/json\" href=\"https://frdaguidelines.org/wp-json/wp/v2/pages/1051\" /><link rel=\"EditURI\" type=\"application/rsd+xml\" title=\"RSD\" href=\"https://frdaguidelines.org/xmlrpc.php?rsd\" />\n<meta name=\"generator\" content=\"WordPress 6.4.1\" />\n<link rel='shortlink' href='https://frdaguidelines.org/?p=1051' />\n<link rel=\"alternate\" type=\"application/json+oembed\" href=\"https://frdaguidelines.org/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ffrdaguidelines.org%2F1-1%2F\" />\n<link rel=\"alternate\" type=\"text/xml+oembed\" href=\"https://frdaguidelines.org/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ffrdaguidelines.org%2F1-1%2F&#038;format=xml\" />\n<meta name=\"bmi-version\" content=\"1.2.8\" /><style id=\"ashe_dynamic_css\">body {background-color: #ffffff;}#top-bar {background-color: #ffffff;}#top-bar a {color: #000000;}#top-bar a:hover,#top-bar li.current-menu-item > a,#top-bar li.current-menu-ancestor > a,#top-bar .sub-menu li.current-menu-item > a,#top-bar .sub-menu li.current-menu-ancestor> a {color: #ca9b52;}#top-menu .sub-menu,#top-menu .sub-menu a {background-color: #ffffff;border-color: rgba(0,0,0, 0.05);}@media screen and ( max-width: 979px ) {.top-bar-socials {float: none !important;}.top-bar-socials a {line-height: 40px !important;}}.header-logo a,.site-description {color: #111;}.entry-header {background-color: #ffffff;}#main-nav {background-color: #ffffff;box-shadow: 0px 1px 5px rgba(0,0,0, 0.1);}#featured-links h6 {background-color: rgba(255,255,255, 0.85);color: #000000;}#main-nav a,#main-nav i,#main-nav #s {color: #000000;}.main-nav-sidebar span,.sidebar-alt-close-btn span {background-color: #000000;}#main-nav a:hover,#main-nav i:hover,#main-nav li.current-menu-item > a,#main-nav li.current-menu-ancestor > a,#main-nav .sub-menu li.current-menu-item > a,#main-nav .sub-menu li.current-menu-ancestor> a {color: #ca9b52;}.main-nav-sidebar:hover span {background-color: #ca9b52;}#main-menu .sub-menu,#main-menu .sub-menu a {background-color: #ffffff;border-color: rgba(0,0,0, 0.05);}#main-nav #s {background-color: #ffffff;}#main-nav #s::-webkit-input-placeholder { /* Chrome/Opera/Safari */color: rgba(0,0,0, 0.7);}#main-nav #s::-moz-placeholder { /* Firefox 19+ */color: rgba(0,0,0, 0.7);}#main-nav #s:-ms-input-placeholder { /* IE 10+ */color: rgba(0,0,0, 0.7);}#main-nav #s:-moz-placeholder { /* Firefox 18- */color: rgba(0,0,0, 0.7);}/* Background */.sidebar-alt,#featured-links,.main-content,.featured-slider-area,.page-content select,.page-content input,.page-content textarea {background-color: #ffffff;}/* Text */.page-content,.page-content select,.page-content input,.page-content textarea,.page-content .post-author a,.page-content .ashe-widget a,.page-content .comment-author {color: #464646;}/* Title */.page-content h1,.page-content h2,.page-content h3,.page-content h4,.page-content h5,.page-content h6,.page-content .post-title a,.page-content .author-description h4 a,.page-content .related-posts h4 a,.page-content .blog-pagination .previous-page a,.page-content .blog-pagination .next-page a,blockquote,.page-content .post-share a {color: #030303;}.page-content .post-title a:hover {color: rgba(3,3,3, 0.75);}/* Meta */.page-content .post-date,.page-content .post-comments,.page-content .post-author,.page-content [data-layout*=\"list\"] .post-author a,.page-content .related-post-date,.page-content .comment-meta a,.page-content .author-share a,.page-content .post-tags a,.page-content .tagcloud a,.widget_categories li,.widget_archive li,.ahse-subscribe-box p,.rpwwt-post-author,.rpwwt-post-categories,.rpwwt-post-date,.rpwwt-post-comments-number {color: #a1a1a1;}.page-content input::-webkit-input-placeholder { /* Chrome/Opera/Safari */color: #a1a1a1;}.page-content input::-moz-placeholder { /* Firefox 19+ */color: #a1a1a1;}.page-content input:-ms-input-placeholder { /* IE 10+ */color: #a1a1a1;}.page-content input:-moz-placeholder { /* Firefox 18- */color: #a1a1a1;}/* Accent */a,.post-categories,.page-content .ashe-widget.widget_text a {color: #ca9b52;}/* Disable TMP.page-content .elementor a,.page-content .elementor a:hover {color: inherit;}*/.ps-container > .ps-scrollbar-y-rail > .ps-scrollbar-y {background: #ca9b52;}a:not(.header-logo-a):hover {color: rgba(202,155,82, 0.8);}blockquote {border-color: #ca9b52;}/* Selection */::-moz-selection {color: #ffffff;background: #ca9b52;}::selection {color: #ffffff;background: #ca9b52;}/* Border */.page-content .post-footer,[data-layout*=\"list\"] .blog-grid > li,.page-content .author-description,.page-content .related-posts,.page-content .entry-comments,.page-content .ashe-widget li,.page-content #wp-calendar,.page-content #wp-calendar caption,.page-content #wp-calendar tbody td,.page-content .widget_nav_menu li a,.page-content .tagcloud a,.page-content select,.page-content input,.page-content textarea,.widget-title h2:before,.widget-title h2:after,.post-tags a,.gallery-caption,.wp-caption-text,table tr,table th,table td,pre,.category-description {border-color: #e8e8e8;}hr {background-color: #e8e8e8;}/* Buttons */.widget_search i,.widget_search #searchsubmit,.wp-block-search button,.single-navigation i,.page-content .submit,.page-content .blog-pagination.numeric a,.page-content .blog-pagination.load-more a,.page-content .ashe-subscribe-box input[type=\"submit\"],.page-content .widget_wysija input[type=\"submit\"],.page-content .post-password-form input[type=\"submit\"],.page-content .wpcf7 [type=\"submit\"] {color: #ffffff;background-color: #333333;}.single-navigation i:hover,.page-content .submit:hover,.ashe-boxed-style .page-content .submit:hover,.page-content .blog-pagination.numeric a:hover,.ashe-boxed-style .page-content .blog-pagination.numeric a:hover,.page-content .blog-pagination.numeric span,.page-content .blog-pagination.load-more a:hover,.page-content .ashe-subscribe-box input[type=\"submit\"]:hover,.page-content .widget_wysija input[type=\"submit\"]:hover,.page-content .post-password-form input[type=\"submit\"]:hover,.page-content .wpcf7 [type=\"submit\"]:hover {color: #ffffff;background-color: #ca9b52;}/* Image Overlay */.image-overlay,#infscr-loading,.page-content h4.image-overlay {color: #ffffff;background-color: rgba(73,73,73, 0.3);}.image-overlay a,.post-slider .prev-arrow,.post-slider .next-arrow,.page-content .image-overlay a,#featured-slider .slick-arrow,#featured-slider .slider-dots {color: #ffffff;}.slide-caption {background: rgba(255,255,255, 0.95);}#featured-slider .slick-active {background: #ffffff;}#page-footer,#page-footer select,#page-footer input,#page-footer textarea {background-color: #f6f6f6;color: #333333;}#page-footer,#page-footer a,#page-footer select,#page-footer input,#page-footer textarea {color: #333333;}#page-footer #s::-webkit-input-placeholder { /* Chrome/Opera/Safari */color: #333333;}#page-footer #s::-moz-placeholder { /* Firefox 19+ */color: #333333;}#page-footer #s:-ms-input-placeholder { /* IE 10+ */color: #333333;}#page-footer #s:-moz-placeholder { /* Firefox 18- */color: #333333;}/* Title */#page-footer h1,#page-footer h2,#page-footer h3,#page-footer h4,#page-footer h5,#page-footer h6 {color: #111111;}#page-footer a:hover {color: #ca9b52;}/* Border */#page-footer a,#page-footer .ashe-widget li,#page-footer #wp-calendar,#page-footer #wp-calendar caption,#page-footer #wp-calendar tbody td,#page-footer .widget_nav_menu li a,#page-footer select,#page-footer input,#page-footer textarea,#page-footer .widget-title h2:before,#page-footer .widget-title h2:after,.footer-widgets {border-color: #e0dbdb;}#page-footer hr {background-color: #e0dbdb;}.ashe-preloader-wrap {background-color: #ffffff;}@media screen and ( max-width: 768px ) {.featured-slider-area {display: none;}}@media screen and ( max-width: 768px ) {#featured-links {display: none;}}@media screen and ( max-width: 640px ) {.related-posts {display: none;}}.header-logo a {font-family: 'Open Sans';}#top-menu li a {font-family: 'Open Sans';}#main-menu li a {font-family: 'Open Sans';}#mobile-menu li,.mobile-menu-btn a {font-family: 'Open Sans';}#top-menu li a,#main-menu li a,#mobile-menu li,.mobile-menu-btn a {text-transform: uppercase;}.boxed-wrapper {max-width: 1160px;}.sidebar-alt {max-width: 340px;left: -340px; padding: 85px 35px 0px;}.sidebar-left,.sidebar-right {width: 307px;}.main-container {width: 100%;}#top-bar > div,#main-nav > div,#featured-links,.main-content,.page-footer-inner,.featured-slider-area.boxed-wrapper {padding-left: 40px;padding-right: 40px;}#top-menu {float: left;}.top-bar-socials {float: right;}.entry-header {height: 500px;background-image:url(https://frdaguidelines.org/wp-content/themes/ashe/assets/images/ashe_bg.jpg);background-size: cover;}.entry-header {background-position: center center;}.logo-img {max-width: 500px;}.mini-logo a {max-width: 70px;}#main-nav {text-align: center;}.main-nav-sidebar {position: absolute;top: 0px;left: 40px;z-index: 1;}.main-nav-icons {position: absolute;top: 0px;right: 40px;z-index: 2;}.mini-logo {position: absolute;left: auto;top: 0;}.main-nav-sidebar ~ .mini-logo {margin-left: 30px;}#featured-links .featured-link {margin-right: 20px;}#featured-links .featured-link:last-of-type {margin-right: 0;}#featured-links .featured-link {width: calc( (100% - -20px) / 0 - 1px);width: -webkit-calc( (100% - -20px) / 0- 1px);}.featured-link:nth-child(1) .cv-inner {display: none;}.featured-link:nth-child(2) .cv-inner {display: none;}.featured-link:nth-child(3) .cv-inner {display: none;}.blog-grid > li {width: 100%;margin-bottom: 30px;}.post-content > p:not(.wp-block-tag-cloud):first-of-type:first-letter {font-family: \"Playfair Display\";font-weight: 400;float: left;margin: 0px 12px 0 0;font-size: 80px;line-height: 65px;text-align: center;}.blog-post .post-content > p:not(.wp-block-tag-cloud):first-of-type:first-letter {color: #030303;}@-moz-document url-prefix() {.post-content > p:not(.wp-block-tag-cloud):first-of-type:first-letter {margin-top: 10px !important;}}.footer-widgets > .ashe-widget {width: 30%;margin-right: 5%;}.footer-widgets > .ashe-widget:nth-child(3n+3) {margin-right: 0;}.footer-widgets > .ashe-widget:nth-child(3n+4) {clear: both;}.copyright-info {float: right;}.footer-socials {float: left;}.woocommerce div.product .stock,.woocommerce div.product p.price,.woocommerce div.product span.price,.woocommerce ul.products li.product .price,.woocommerce-Reviews .woocommerce-review__author,.woocommerce form .form-row .required,.woocommerce form .form-row.woocommerce-invalid label,.woocommerce .page-content div.product .woocommerce-tabs ul.tabs li a {color: #464646;}.woocommerce a.remove:hover {color: #464646 !important;}.woocommerce a.remove,.woocommerce .product_meta,.page-content .woocommerce-breadcrumb,.page-content .woocommerce-review-link,.page-content .woocommerce-breadcrumb a,.page-content .woocommerce-MyAccount-navigation-link a,.woocommerce .woocommerce-info:before,.woocommerce .page-content .woocommerce-result-count,.woocommerce-page .page-content .woocommerce-result-count,.woocommerce-Reviews .woocommerce-review__published-date,.woocommerce .product_list_widget .quantity,.woocommerce .widget_products .amount,.woocommerce .widget_price_filter .price_slider_amount,.woocommerce .widget_recently_viewed_products .amount,.woocommerce .widget_top_rated_products .amount,.woocommerce .widget_recent_reviews .reviewer {color: #a1a1a1;}.woocommerce a.remove {color: #a1a1a1 !important;}p.demo_store,.woocommerce-store-notice,.woocommerce span.onsale { background-color: #ca9b52;}.woocommerce .star-rating::before,.woocommerce .star-rating span::before,.woocommerce .page-content ul.products li.product .button,.page-content .woocommerce ul.products li.product .button,.page-content .woocommerce-MyAccount-navigation-link.is-active a,.page-content .woocommerce-MyAccount-navigation-link a:hover { color: #ca9b52;}.woocommerce form.login,.woocommerce form.register,.woocommerce-account fieldset,.woocommerce form.checkout_coupon,.woocommerce .woocommerce-info,.woocommerce .woocommerce-error,.woocommerce .woocommerce-message,.woocommerce .widget_shopping_cart .total,.woocommerce.widget_shopping_cart .total,.woocommerce-Reviews .comment_container,.woocommerce-cart #payment ul.payment_methods,#add_payment_method #payment ul.payment_methods,.woocommerce-checkout #payment ul.payment_methods,.woocommerce div.product .woocommerce-tabs ul.tabs::before,.woocommerce div.product .woocommerce-tabs ul.tabs::after,.woocommerce div.product .woocommerce-tabs ul.tabs li,.woocommerce .woocommerce-MyAccount-navigation-link,.select2-container--default .select2-selection--single {border-color: #e8e8e8;}.woocommerce-cart #payment,#add_payment_method #payment,.woocommerce-checkout #payment,.woocommerce .woocommerce-info,.woocommerce .woocommerce-error,.woocommerce .woocommerce-message,.woocommerce div.product .woocommerce-tabs ul.tabs li {background-color: rgba(232,232,232, 0.3);}.woocommerce-cart #payment div.payment_box::before,#add_payment_method #payment div.payment_box::before,.woocommerce-checkout #payment div.payment_box::before {border-color: rgba(232,232,232, 0.5);}.woocommerce-cart #payment div.payment_box,#add_payment_method #payment div.payment_box,.woocommerce-checkout #payment div.payment_box {background-color: rgba(232,232,232, 0.5);}.page-content .woocommerce input.button,.page-content .woocommerce a.button,.page-content .woocommerce a.button.alt,.page-content .woocommerce button.button.alt,.page-content .woocommerce input.button.alt,.page-content .woocommerce #respond input#submit.alt,.woocommerce .page-content .widget_product_search input[type=\"submit\"],.woocommerce .page-content .woocommerce-message .button,.woocommerce .page-content a.button.alt,.woocommerce .page-content button.button.alt,.woocommerce .page-content #respond input#submit,.woocommerce .page-content .widget_price_filter .button,.woocommerce .page-content .woocommerce-message .button,.woocommerce-page .page-content .woocommerce-message .button,.woocommerce .page-content nav.woocommerce-pagination ul li a,.woocommerce .page-content nav.woocommerce-pagination ul li span {color: #ffffff;background-color: #333333;}.page-content .woocommerce input.button:hover,.page-content .woocommerce a.button:hover,.page-content .woocommerce a.button.alt:hover,.ashe-boxed-style .page-content .woocommerce a.button.alt:hover,.page-content .woocommerce button.button.alt:hover,.page-content .woocommerce input.button.alt:hover,.page-content .woocommerce #respond input#submit.alt:hover,.woocommerce .page-content .woocommerce-message .button:hover,.woocommerce .page-content a.button.alt:hover,.woocommerce .page-content button.button.alt:hover,.ashe-boxed-style.woocommerce .page-content button.button.alt:hover,.ashe-boxed-style.woocommerce .page-content #respond input#submit:hover,.woocommerce .page-content #respond input#submit:hover,.woocommerce .page-content .widget_price_filter .button:hover,.woocommerce .page-content .woocommerce-message .button:hover,.woocommerce-page .page-content .woocommerce-message .button:hover,.woocommerce .page-content nav.woocommerce-pagination ul li a:hover,.woocommerce .page-content nav.woocommerce-pagination ul li span.current {color: #ffffff;background-color: #ca9b52;}.woocommerce .page-content nav.woocommerce-pagination ul li a.prev,.woocommerce .page-content nav.woocommerce-pagination ul li a.next {color: #333333;}.woocommerce .page-content nav.woocommerce-pagination ul li a.prev:hover,.woocommerce .page-content nav.woocommerce-pagination ul li a.next:hover {color: #ca9b52;}.woocommerce .page-content nav.woocommerce-pagination ul li a.prev:after,.woocommerce .page-content nav.woocommerce-pagination ul li a.next:after {color: #ffffff;}.woocommerce .page-content nav.woocommerce-pagination ul li a.prev:hover:after,.woocommerce .page-content nav.woocommerce-pagination ul li a.next:hover:after {color: #ffffff;}.cssload-cube{background-color:#333333;width:9px;height:9px;position:absolute;margin:auto;animation:cssload-cubemove 2s infinite ease-in-out;-o-animation:cssload-cubemove 2s infinite ease-in-out;-ms-animation:cssload-cubemove 2s infinite ease-in-out;-webkit-animation:cssload-cubemove 2s infinite ease-in-out;-moz-animation:cssload-cubemove 2s infinite ease-in-out}.cssload-cube1{left:13px;top:0;animation-delay:.1s;-o-animation-delay:.1s;-ms-animation-delay:.1s;-webkit-animation-delay:.1s;-moz-animation-delay:.1s}.cssload-cube2{left:25px;top:0;animation-delay:.2s;-o-animation-delay:.2s;-ms-animation-delay:.2s;-webkit-animation-delay:.2s;-moz-animation-delay:.2s}.cssload-cube3{left:38px;top:0;animation-delay:.3s;-o-animation-delay:.3s;-ms-animation-delay:.3s;-webkit-animation-delay:.3s;-moz-animation-delay:.3s}.cssload-cube4{left:0;top:13px;animation-delay:.1s;-o-animation-delay:.1s;-ms-animation-delay:.1s;-webkit-animation-delay:.1s;-moz-animation-delay:.1s}.cssload-cube5{left:13px;top:13px;animation-delay:.2s;-o-animation-delay:.2s;-ms-animation-delay:.2s;-webkit-animation-delay:.2s;-moz-animation-delay:.2s}.cssload-cube6{left:25px;top:13px;animation-delay:.3s;-o-animation-delay:.3s;-ms-animation-delay:.3s;-webkit-animation-delay:.3s;-moz-animation-delay:.3s}.cssload-cube7{left:38px;top:13px;animation-delay:.4s;-o-animation-delay:.4s;-ms-animation-delay:.4s;-webkit-animation-delay:.4s;-moz-animation-delay:.4s}.cssload-cube8{left:0;top:25px;animation-delay:.2s;-o-animation-delay:.2s;-ms-animation-delay:.2s;-webkit-animation-delay:.2s;-moz-animation-delay:.2s}.cssload-cube9{left:13px;top:25px;animation-delay:.3s;-o-animation-delay:.3s;-ms-animation-delay:.3s;-webkit-animation-delay:.3s;-moz-animation-delay:.3s}.cssload-cube10{left:25px;top:25px;animation-delay:.4s;-o-animation-delay:.4s;-ms-animation-delay:.4s;-webkit-animation-delay:.4s;-moz-animation-delay:.4s}.cssload-cube11{left:38px;top:25px;animation-delay:.5s;-o-animation-delay:.5s;-ms-animation-delay:.5s;-webkit-animation-delay:.5s;-moz-animation-delay:.5s}.cssload-cube12{left:0;top:38px;animation-delay:.3s;-o-animation-delay:.3s;-ms-animation-delay:.3s;-webkit-animation-delay:.3s;-moz-animation-delay:.3s}.cssload-cube13{left:13px;top:38px;animation-delay:.4s;-o-animation-delay:.4s;-ms-animation-delay:.4s;-webkit-animation-delay:.4s;-moz-animation-delay:.4s}.cssload-cube14{left:25px;top:38px;animation-delay:.5s;-o-animation-delay:.5s;-ms-animation-delay:.5s;-webkit-animation-delay:.5s;-moz-animation-delay:.5s}.cssload-cube15{left:38px;top:38px;animation-delay:.6s;-o-animation-delay:.6s;-ms-animation-delay:.6s;-webkit-animation-delay:.6s;-moz-animation-delay:.6s}.cssload-spinner{margin:auto;width:49px;height:49px;position:relative}@keyframes cssload-cubemove{35%{transform:scale(0.005)}50%{transform:scale(1.7)}65%{transform:scale(0.005)}}@-o-keyframes cssload-cubemove{35%{-o-transform:scale(0.005)}50%{-o-transform:scale(1.7)}65%{-o-transform:scale(0.005)}}@-ms-keyframes cssload-cubemove{35%{-ms-transform:scale(0.005)}50%{-ms-transform:scale(1.7)}65%{-ms-transform:scale(0.005)}}@-webkit-keyframes cssload-cubemove{35%{-webkit-transform:scale(0.005)}50%{-webkit-transform:scale(1.7)}65%{-webkit-transform:scale(0.005)}}@-moz-keyframes cssload-cubemove{35%{-moz-transform:scale(0.005)}50%{-moz-transform:scale(1.7)}65%{-moz-transform:scale(0.005)}}.main-nav-sidebar div {max-height: 70px;}#main-nav {min-height: 70px;}#main-menu li a,.mobile-menu-btn,.dark-mode-switcher,.main-nav-socials a,.main-nav-search,#main-nav #s {line-height: 70px;}.main-nav-sidebar,.mini-logo {height: 70px;}</style><style id=\"ashe_theme_styles\"></style>\t\t<style type=\"text/css\" id=\"wp-custom-css\">\n\t\t\ta { color:#1111BB; }\nsummary { font-size:.9rem; font-weight:bold; cursor:pointer; padding-left:9px; background-color:#EEEEEE;}\ndetails p { padding:9px 9px 0px 9px;}\ndetails table { margin:9px }\ndetails { border:1px #BBBBBB solid; border-radius:6px; margin:25px 0px 15px 0px }\nh1, h2, h3, h4, h5, h6 {font-family:Arial, Helvitica; }\n { font-family:Arial, Helvitica; font-size:14pt; padding-top:9px }\n.page-content h1, .page-content h2,.page-content h3 { color:#222299; } \n.page-title {font-family:Arial, sans-serif; font-size:1.6em; }\n.post-title { font-size:1.6em; }\n.post-content { display:none; }\n.post-comments { display:none; }\n.qmark { width:15px; display:inline; margin:0px 9px 0px 4px; position:relative; top:3px; z-index:999; }\nh1 { font-size:1.8em; }\nh2 { font-size:1.6em; }\nh3 { font-size:1.4em;}\nh4 { font-size:1em; font-weight:bold;}\nh5 { font-size:1em;}\nh6 { font-size:1em;}\nh7 { font-size:1em; font-style:italic;}\nhr { height:2px; background-color:EEEEEE;}\n//.read-more { display:none;}\t\t</style>\n\t\t</head>\n\n<body class=\"page-template-default page page-id-1051 wp-embed-responsive\">\n<img src=\"https://frdaguidelines.org/images/header.jpg\" style=\"width:100%;\" />\n<center><br/>\n  <b style=\"font-size:18pt; color:#222299;\">Clinical Management Guidelines for Friedreich Ataxia (FRDA)</b>\t\n</center>\n<div id=\"main-nav\" class=\"clear-fix\">\n\t<div class=\"boxed-wrapper\">\t\n\t\t<div class=\"main-nav-icons\">\t\n\t\t\t<div class=\"main-nav-search\">\n\t\t\t\t<i class=\"fa fa-search\"></i>\n\t\t\t\t<i class=\"fa fa-times\"></i>\n\t\t\t\t<form role=\"search\" method=\"get\" id=\"searchform\" class=\"clear-fix\" action=\"https://frdaguidelines.org/\"><input type=\"search\" name=\"s\" \n        id=\"s\" placeholder=\"Search...\" data-placeholder=\"Type then hit Enter...\" value=\"\" /><i class=\"fa fa-search\"></i><input type=\"submit\" \n        id=\"searchsubmit\" value=\"st\" /></form>\n      </div>\n\t\t</div>\n\t\t<nav class=\"main-menu-container\">\n      <ul id=\"main-menu\" class=\"\"><li id=\"menu-item-276\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-home current-menu-item page_item page-item-9 current_page_item menu-item-276\"><a href=\"https://frdaguidelines.org/\" aria-current=\"page\">HOME</a></li>\n<li id=\"menu-item-272\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-272\"><a href=\"https://frdaguidelines.org/table-of-contents/\">TABLE&nbsp;OF&nbsp;CONTENTS</a></li>\n<li id=\"menu-item-372\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-372\"><a href=\"https://frdaguidelines.org/abbreviations/\">ABBREVIATIONS</a></li>\n<li id=\"menu-item-678\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-678\"><a href=\"https://frdaguidelines.org/feedback/\">SEND&nbsp;FEEDBACK</a></li>\n<li id=\"menu-item-751\" class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-751\"><a style=\"color:#CC2222;\" \nhref=\"https://frdaguidelines.org/chapter-15-emergency-department-presentations-for-friedreich-ataxia/\">EMERGENCY&nbsp;CARE</a></li>\n</ul></nav>\n\t\t<!-- Mobile Menu Button -->\n\t\t<span class=\"mobile-menu-btn\">\n\t\t\t<i class=\"fa fa-chevron-down\"></i>\t\t</span>\n\n\t\t<nav class=\"mobile-menu-container\"><ul id=\"mobile-menu\" class=\"\"><li class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-home current-menu-item page_item page-item-9 current_page_item menu-item-276\"><a href=\"https://frdaguidelines.org/\" aria-current=\"page\">HOME</a></li>\n<li class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-272\"><a href=\"https://frdaguidelines.org/table-of-contents/\">TABLE OF CONTENTS</a></li>\n<li class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-372\"><a href=\"https://frdaguidelines.org/abbreviations/\">ABBREVIATIONS</a></li>\n<li class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-678\"><a href=\"https://frdaguidelines.org/feedback/\">SEND FEEDBACK</a></li>\n<li class=\"menu-item menu-item-type-post_type menu-item-object-page menu-item-751\"><a style=\"color:#CC2222;\"href=\"https://frdaguidelines.org/chapter-15-emergency-department-presentations-for-friedreich-ataxia/\">EMERGENCY&nbsp;CARE</a></li>\n </ul></nav>\n\t</div>\n</div>\n\t\n\t\n\t<!-- Preloader -->\n\t\n\t<!-- Page Wrapper -->\n\t<div id=\"page-wrap\">\n\n\t\t<!-- Boxed Wrapper -->\n\t\t<div id=\"page-header\" >\n\n\t\t\n\t\t</div><!-- .boxed-wrapper -->\n\n\t\t<!-- Page Content -->\n\t\t<div class=\"page-content\">\n\n\t\t\t\n\t\t\t\n<div class=\"main-content clear-fix boxed-wrapper\" data-sidebar-sticky=\"1\">\n\t\n\t\n\t<!-- Main Container -->\n\t<div class=\"main-container\">\n\t\t\n\t\t<article id=\"page-1051\" class=\"post-1051 page type-page status-publish hentry\">\n\n\t\t\t<header class=\"post-header\"><h1 class=\"page-title\">Topic 1.1. Clinical Features of Friedreich ataxia</h1></header><div ><p><center><a href=\"https://frdaguidelines.org/chp1overview/\" class=\"su-button su-button-style-glass\" style=\"color:#FFFFFF;background-color:#2D89EF;border-color:#246ec0;border-radius:5px;-moz-border-radius:5px;-webkit-border-radius:5px\" target=\"_self\"><span style=\"color:#FFFFFF;padding:0px 16px;font-size:13px;line-height:26px;border-color:#6cadf4;border-radius:5px;-moz-border-radius:5px;-webkit-border-radius:5px;text-shadow:none;-moz-text-shadow:none;-webkit-text-shadow:none\"> <b>Return to Chapter Overview</b></span></a></center><br />\n<center><a href=\"https://frdaguidelines.org/wp-content/uploads/2022/10/1.-Overview-of-Friedreich-ataxia_Final_30May22-1.pdf\" class=\"su-button su-button-style-glass\" style=\"color:#FFFFFF;background-color:#2D89EF;border-color:#246ec0;border-radius:5px;-moz-border-radius:5px;-webkit-border-radius:5px\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"color:#FFFFFF;padding:0px 16px;font-size:13px;line-height:26px;border-color:#6cadf4;border-radius:5px;-moz-border-radius:5px;-webkit-border-radius:5px;text-shadow:none;-moz-text-shadow:none;-webkit-text-shadow:none\"> <b>Full Chapter PDF</b></span></a></center></p>\n<div class=\"su-tabs su-tabs-style-default su-tabs-mobile-desktop\" data-active=\"1\" data-scroll-offset=\"0\" data-anchor-in-url=\"no\"><div class=\"su-tabs-nav\"><span class=\"\" data-url=\"\" data-target=\"blank\" tabindex=\"0\" role=\"button\"><strong>Full Text</strong></span><span class=\"\" data-url=\"\" data-target=\"blank\" tabindex=\"0\" role=\"button\"><strong>Authors</strong></span><span class=\"\" data-url=\"\" data-target=\"blank\" tabindex=\"0\" role=\"button\"><strong>References</strong></span><span class=\"\" data-url=\"\" data-target=\"blank\" tabindex=\"0\" role=\"button\"><strong>Methodology &amp; Date</strong></span></div><div class=\"su-tabs-panes\"><div class=\"su-tabs-pane su-u-clearfix su-u-trim\" data-title=\"&lt;strong&gt;Full Text&lt;/strong&gt;\">\n\n<p><em>This chapter of the Clinical Management Guidelines for Friedreich Ataxia and the recommendations and best practice statements contained herein were endorsed by the authors and the Friedreich Ataxia Guidelines Panel in 2022.</em></p>\n\n<details>\n<summary>Topic Contents</summary>\n<p><a href=\"#1-1\">1.1 Clinical features of Friedreich ataxia</a><br />\n<a href=\"#1-1-1\">1.1.1 Symptom onset and presenting symptoms</a><br />\n<a href=\"#1-1-2\">1.1.2 Diagnostic criteria</a><br />\n<a href=\"#1-1-3\">1.1.3 Incidence and progression of clinical features</a><br />\n</details>\n<details>\n<summary>Disclaimer / Intended Use / Funding</summary>\n\n<p><strong>Disclaimer</strong><br>The Clinical Management Guidelines for Friedreich ataxia (‘Guidelines’) are protected by copyright owned by the authors who contributed to their development or said authors’ assignees.</p>\n\n\n\n<p>These Guidelines are systematically developed evidence statements incorporating data from a comprehensive literature review of the most recent studies available (up to the Guidelines submission date) and reviewed according to the Grading of Recommendations, Assessment Development and Evaluations (GRADE) framework © The Grade Working Group.</p>\n\n\n\n<p>Guidelines users must seek out the most recent information that might supersede the diagnostic and treatment recommendations contained within these Guidelines and consider local variations in clinical settings, funding and resources that may impact on the implementation of the recommendations set out in these Guidelines.</p>\n\n\n\n<p>The authors of these Guidelines disclaim all liability for the accuracy or completeness of the Guidelines, and disclaim all warranties, express or implied to their incorrect use.</p>\n\n\n\n<p><strong>Intended Use</strong><br>These Guidelines are made available as general information only and do not constitute medical advice. These Guidelines are intended to assist qualified healthcare professionals make informed treatment decisions about the care of individuals with Friedreich ataxia. They are not intended as a sole source of guidance in managing issues related to Friedreich ataxia. Rather, they are designed to assist clinicians by providing an evidence-based framework for decision-making.</p>\n\n\n\n<p>These Guidelines are not intended to replace clinical judgment and other approaches to diagnosing and managing problems associated with Friedreich ataxia which may be appropriate in specific circumstances. Ultimately, healthcare professionals must make their own treatment decisions on a case-by-case basis, after consultation with their patients, using their clinical judgment, knowledge and expertise.<br>Guidelines users must not edit or modify the Guidelines in any way – including removing any branding, acknowledgement, authorship or copyright notice.</p>\n\n\n\n<p><strong>Funding</strong><br>The authors of this document gratefully acknowledge the support of the Friedreich Ataxia Research Alliance (FARA). The views and opinions expressed in the Guidelines are solely those of the authors and do not necessarily reflect the official policy or position of FARA.</p>\n\n</details>\n<hr/>\n<h2 id=\"1-1\">1.1 Clinical features of Friedreich ataxia</h2>\n<p><em><strong>Antoine Duquette and Ludger Schöls</strong></em></p>\n<h3 id=\"1-1-1\">1.1.1 Symptom onset and presenting symptoms</h3>\n<p>The disease which came to be known as Friedreich ataxia (FRDA) (1) was first described by the German pathologist Nikolaus Friedreich in a series of five papers published between 1863 and 1877 (2-6). At the time, Friedreich described a new hereditary spinal disease associated with kyphoscoliosis and fatty degeneration of the heart. The disease is most often caused by a pathogenic expansion in the first intron of the frataxin gene (7) and the size of the expansion influences the clinical presentation. Typically, the disease begins in early adolescence with gait instability (8). Scoliosis may also be the initial symptom, especially in patients with a younger age of onset (8).</p>\n<h3 id=\"1-1-2\">1.1.2 Diagnostic criteria</h3>\n<p>The first set of diagnostic criteria for FRDA were proposed by Geoffroy and colleagues in 1976 (9). Seven primary signs and symptoms were considered obligatory for diagnosis: onset before the end of puberty and never after the age of 20; ataxia of gait; progression of ataxia within the last two years; dysarthria; decrease of joint position and/or vibration sense in lower limbs; muscle weakness; and deep tendon areflexia in the lower limbs. Four clinical features were considered secondary, but not obligatory for diagnosis: extensor plantar response; pes cavus; scoliosis; and cardiomyopathy. These criteria, however, proved to be difficult to use in younger individuals in whom some of the features deemed to be obligatory, such as muscle weakness and sensory loss, would develop later. To overcome this challenge, Anita Harding proposed a new set of criteria (10). Obligatory criteria included an onset of symptoms before the age of 25, progressive unremitting ataxia of the limbs and gait, as well as absence of the knee and ankle jerks. Dysarthria and extensor plantar responses were considered important secondary criteria.</p>\n<p>While diagnostic criteria have been critical to guide research and clinical care, they restricted the expected presentation of individuals with FRDA. The identification of the genetic basis of the disease (7) has led to a significant expansion of clinical phenotypes associated with FRDA. The limitations of the criteria rapidly became apparent as genetically confirmed individuals had onset after the age of 25 or with retained tendon reflexes (11, 12). In fact, the phenotype of late-onset FRDA is often predominantly spasticity with very little ataxia (13).</p>\n<h3 id=\"1-1-3\">1.1.3 Incidence and progression of clinical features</h3>\n<h4>Neurological signs and symptoms</h4>\n<p>In longitudinal studies, the neurological symptoms progress over time. Loss of ambulation obviously has a significant impact on independence and quality of life. For individuals with disease onset before the age of 15, loss of ambulation occurs on average 11.5 years after disease onset with the sequential loss of stance with feet apart and eyes closed, followed by stance with feet together and, finally, normal stance (14). Dysarthria is a nearly universal feature in FRDA (11, 12, 15) and spectral measures can detect changes in speech over time (16). The prevalence and frequency of ocular square-wave jerks increases over time, but this rarely translates into functional impairment (17). Overall, using the Friedreich Ataxia Rating Scale (FARS), the disease seems to progress faster in younger individuals (18). While disease progression may indeed slow down with time, this could also reflect the limitations of clinical scales currently in use.</p>\n<h4>Neurogenic bladder</h4>\n<p>Lower urinary tract symptoms, including hesitancy, retention, urgency, and incontinence, have been reported in 59% to 82% of individuals with FRDA (19, 20).</p>\n<h4>Orthopedic involvement</h4>\n<p>In cohorts with genetically confirmed FRDA, between 60% and 84% have scoliosis (11, 12, 15, 21). Pes cavus, which is slightly less frequent, is also observed in a majority of individuals with FRDA (11, 12, 15, 21).</p>\n<h4>Cardiac involvement and diabetes mellitus</h4>\n<p>Heart involvement in FRDA has been described by Nikolaus Friedreich in his original series of publications and cardiac disease is recognized as the most common cause of mortality in FRDA (22). In fact, in addition to GAA repeat length, left ventricular mass index and left ventricular ejection fraction are independent predictors of mortality (23). ECG abnormalities such as T-wave inversions are found in 83% of individuals with FRDA (12). While 78.6% of people with FRDA exhibit normal left ventricular function, ejection fraction declines slowly over time even if it remains within the normal range (23).</p>\n<p>Diabetes mellitus is another significant issue associated with FRDA and often requires insulin therapy; prevalence has been estimated to be between 8% and 32% (11, 12, 15).</p>\n<h4>Visual impairment and hearing loss</h4>\n<p>While clinically significant visual loss is reported in a minority of people with FRDA, anterior and posterior visual pathway involvement is nearly universal (24). Hearing loss is also increased in FRDA relative to the general population, and abnormal speech perception has been described in up to 90% of people with FRDA (25).</div>\n<div class=\"su-tabs-pane su-u-clearfix su-u-trim\" data-title=\"&lt;strong&gt;Authors&lt;/strong&gt;\">\n<strong>Antoine Duquette,</strong> <strong>MD, MSc, FRCP(C)</strong><br />\nAssociate Clinical Professor, Centre hospitalier de l’Université de Montréal, Montréal, Québec, Canada<br />\nEmail: <a href=\"mailto:antoine.duquette@umontreal.ca\">antoine.duquette@umontreal.ca</a></p>\n<p><strong>Ludger Schöls, MD</strong><br />\nProfessor of Neurology, Eberhard-Karls University, Tübingen, Germany<br />\nEmail: <a href=\"mailto:Ludger.Schoels@uni-tuebingen.de\">Ludger.Schoels@uni-tuebingen.de</a><br />\n</div>\n<div class=\"su-tabs-pane su-u-clearfix su-u-trim\" data-title=\"&lt;strong&gt;References&lt;/strong&gt;\">\n1. Brousse M. De l’ataxie héréditaire: Thèse de Montpelier; 1882.</p>\n<p>2. Friedreich N. Uber degenerative Atrophie der spinalen Hinterstrange. Virchow&#8217;s Arch Path Anat. 1863;26:291-419.</p>\n<p>3. Friedreich N. Uber degenerative Atrophie der spinalen Hinterstrange. Virchow&#8217;s Arch Path Anat. 1863;27:1-26.</p>\n<p>4. Friedreich N. Uber degenerative Atrophie der spinalen Hinterstrange. Virchow&#8217;s Arch Path Anat. 1863;26:433-59.</p>\n<p>5. Friedreich N. Uber ataxie mit besonderer berucksichtigung der herditaren formen. Virchow&#8217;s Arch Path Anat. 1876;68:145-245.</p>\n<p>6. Friedreich N. Uber ataxie mit besonderer berucksichtigung der hereditaren formen. Virchow&#8217;s Arch Path Anat. 1877;70:140-52.</p>\n<p>7. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, et al. Friedreich&#8217;s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271(5254):1423-7.</p>\n<p>8. Reetz K, Dogan I, Costa AS, Dafotakis M, Fedosov K, Giunti P, et al. Biological and clinical characteristics of the European Friedreich&#8217;s Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data. Lancet Neurol. 2015;14(2):174-82.</p>\n<p>9. Geoffroy G, Barbeau A, Breton G, Lemieux B, Aube M, Leger C, et al. Clinical description and roentgenologic evaluation of patients with Friedreich&#8217;s ataxia. Can J Neurol Sci. 1976;3(4):279-86.</p>\n<p>10. Harding AE. Friedreich&#8217;s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain. 1981;104(3):589-620.</p>\n<p>11. Dürr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, et al. Clinical and genetic abnormalities in patients with Friedreich&#8217;s ataxia. N Engl J Med. 1996;335(16):1169-75.</p>\n<p>12. Schöls L, Amoiridis G, Przuntek H, Frank G, Epplen JT, Epplen C. Friedreich&#8217;s ataxia. Revision of the phenotype according to molecular genetics. Brain. 1997;120(Pt 12):2131-40.</p>\n<p>13. Bürk K. Friedreich ataxia: current status and future prospects. Cerebellum Ataxias. 2017;4:4.</p>\n<p>14. Rummey C, Farmer JM, Lynch DR. Predictors of loss of ambulation in Friedreich&#8217;s ataxia. EClinicalMedicine. 2020;18:100213.</p>\n<p>15. Delatycki MB, Paris DB, Gardner RJ, Nicholson GA, Nassif N, Storey E, et al. Clinical and genetic study of Friedreich ataxia in an Australian population. Am J Med Genet. 1999;87(2):168-74.</p>\n<p>16. Rosen KM, Folker JE, Vogel AP, Corben LA, Murdoch BE, Delatycki MB. Longitudinal change in dysarthria associated with Friedreich ataxia: a potential clinical endpoint. J Neurol. 2012;259(11):2471-7.</p>\n<p>17. Ribaï P, Pousset F, Tanguy M, Rivaud-Pechoux S, Le Ber I, Gasparini F, et al. Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up. Arch Neurol. 2007;64:558-64.</p>\n<p>18. Patel M, Isaacs CJ, Seyer L, Brigatti K, Gelbard S, Strawser C, et al. Progression of Friedreich ataxia: quantitative characterization over 5 years. Ann Clin Transl Neurol. 2016;3(9):684-94.</p>\n<p>19. Delatycki MB, Corben LA. Clinical features of Friedreich ataxia. J Child Neurol. 2012;27(9):1133-7.</p>\n<p>20. Musegante A, Almeda P, Monteiro R, Bassoro U. Urinary symptoms and urodynamics findings in patients with Friedreich&#8217;s ataxia. International Brazilian Journal of Urology. 2013;39(6):867-74.</p>\n<p>21. McCabe DJ, Ryan F, Moore DP, McQuaid S, King MD, Kelly A, et al. Typical Friedreich&#8217;s ataxia without GAA expansions and GAA expansion without typical Friedreich&#8217;s ataxia.[erratum appears in J Neurol 2000 Jun;247(6):483]. J Neurol. 2000;247(5):346-55.</p>\n<p>22. Tsou AY, Paulsen EK, Lagedrost SJ, Perlman SL, Mathews KD, Wilmot GR, et al. Mortality in Friedreich ataxia. J Neurol Sci. 2011;307:46-9.</p>\n<p>23. Pousset F, Legrand L, Monin ML, Ewenczyk C, Charles P, Komajda M, et al. A 22-year follow-up study of long-term cardiac outcome and predictors of survival in Friedreich ataxia. JAMA Neurol. 2015;72(11):1334-41.</p>\n<p>24. Fortuna F, Barboni P, Liguori R, Valentino ML, Savini G, Gellera C, et al. Visual system involvement in patients with Friedreich&#8217;s ataxia. Brain. 2009;132(Pt 1):116-23.</p>\n<p>25. Rance G, Fava R, Baldock H, Chong A, Barker E, Corben L, et al. Speech perception ability in individuals with Friedreich ataxia. Brain. 2008;131:2002-12.</p>\n<p>26. Galea CA, Huq A, Lockhart PJ, Tai G, Corben LA, Yiu EM, et al. Compound heterozygous FXN mutations and clinical outcome in Friedreich ataxia. Ann Neurol. 2016;79(3):485-95.</p>\n<p>27. Colombo R, Carobene A. Age of the intronic GAA triplet repeat expansion mutation in Friedreich ataxia. Hum Genet. 2000;106(4):455-8.</p>\n<p>28. Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet. 1997;6(11):1771-80.</p>\n<p>29. Li Y, Lu Y, Polak U, Lin K, Shen J, Farmer J, et al. Expanded GAA repeats impede transcription elongation through the FXN gene and induce transcriptional silencing that is restricted to the FXN locus. Hum Mol Genet. 2015;24(24):6932-43.</p>\n<p>30. Rodden LN, Chutake YK, Gilliam K, Lam C, Soragni E, Hauser L, et al. Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia. Hum Mol Genet. 2021;29(23):3818-29.</p>\n<p>31. Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, Gottesfeld JG. Histone deacetylase inhibitors reverse gene silencing in Friedreich’s ataxia. Nat Chem Biol. 2006;2(10):551-8.</p>\n<p>32. Li L, Matsui M, Corey DR. Activating frataxin expression by repeat-targeted nucleic acids. Nat Commun. 2016;7:10606.</p>\n<p>33. Gervason S, Larkem D, Mansour AB, Botzanowski T, Muller CS, Pecqueur L, et al. Physiologically relevant reconstitution of iron-sulfur cluster biosynthesis uncovers persulfide-processing functions of ferredoxin-2 and frataxin. Nat Commun. 2019;10(1):3566.</p>\n<p>34. Gonzalez-Cabo P, Palau F. Mitochondrial pathophysiology in Friedreich&#8217;s ataxia. J Neurochem. 2013;126 Suppl 1:53-64.</p>\n<p>35. Koeppen AH. Friedreich&#8217;s ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci. 2011;303(1-2):1-12.</p>\n<p>36. Harding IH, Lynch DR, Koeppen AH, Pandolfo M. Central nervous system therapeutic targets in Friedreich ataxia. Hum Gene Ther. 2020;31(23-24):1226-36.</p>\n<p>37. Koeppen AH, Becker AB, Qian J, Feustel PJ. Friedreich Ataxia: Hypoplasia of Spinal Cord and Dorsal Root Ganglia. J Neuropathol Exp Neurol. 2017;76(2):101-8.</p>\n<p>38. Koeppen AH, Becker AB, Qian J, Gelman BB, Mazurkiewicz JE. Friedreich Ataxia: Developmental Failure of the Dorsal Root Entry Zone. J Neuropathol Exp Neurol. 2017;76(11):969-77.</p>\n<p>39. Dogan I, Romanzetti S, Didszun C, Mirzazade S, Timmann D, Saft C, et al. Structural characteristics of the central nervous system in Friedreich ataxia: an in vivo spinal cord and brain MRI study. J Neurol Neurosurg Psychiatry. 2019;90(5):615-7.</p>\n<p>40. Dogan I, Tinnemann E, Romanzetti S, Mirzazade S, Costa AS, Werner CJ, et al. Cognition in Friedreich&#8217;s ataxia: a behavioral and multimodal imaging study. Ann Clin Transl Neurol. 2016;3(8):572-87.</p>\n<p>41. Lindig T, Bender B, Kumar VJ, Hauser TK, Grodd W, Brendel B, et al. Pattern of cerebellar atrophy in Friedreich&#8217;s ataxia-using the SUIT template. Cerebellum. 2019;18(3):435-47.</p>\n<p>42. Rezende TJR, Martinez ARM, Faber I, Girotto Takazaki KA, Martins MP, de Lima FD, et al. Developmental and neurodegenerative damage in Friedreich&#8217;s ataxia. Eur J Neurol. 2019;26(3):483-9.</p>\n<p>43. Selvadurai LP, Corben LA, Delatycki MB, Storey E, Egan GF, Georgiou-Karistianis N, et al. Multiple mechanisms underpin cerebral and cerebellar white matter deficits in Friedreich ataxia: The IMAGE-FRDA study. Hum Brain Mapp. 2020;41(7):1920-33.</p>\n<p>44. Vavla M, Arrigoni F, Nordio A, De Luca A, Pizzighello S, Petacchi E, et al. Functional and structural brain damage in Friedreich&#8217;s ataxia. Front Neurol. 2018;9:747.</p>\n<p>45. Ward PGD, Harding IH, Close TG, Corben LA, Delatycki MB, Storey E, et al. Longitudinal evaluation of iron concentration and atrophy in the dentate nuclei in friedreich ataxia. Mov Disord. 2019;34(3):335-43.</p>\n<p>46. Gramegna LL, Tonon C, Manners DN, Pini A, Rinaldi R, Zanigni S, et al. Combined cerebellar proton MR spectroscopy and DWI study of patients with Friedreich&#8217;s ataxia. Cerebellum. 2017;16(1):82-8.</p>\n<p>47. Öz G, Harding IH, Krahe J, Reetz K. MR imaging and spectroscopy in degenerative ataxias: toward multimodal, multisite, multistage monitoring of neurodegeneration. Curr Opin Neurol. 2020;33(4):451-61.</p>\n<p>48. Cocozza S, Costabile T, Tedeschi E, Abate F, Russo C, Liguori A, et al. Cognitive and functional connectivity alterations in Friedreich&#8217;s ataxia. Ann Clin Transl Neurol. 2018;5(6):677-86.</p>\n<p>49. Survey of the delay in diagnosis for 8 rare diseases in Europe (‘EurordisCare2’) 2007 [Available from: https://www.eurordis.org/publication/survey-delay-diagnosis-8-rare-diseases-europe-‘eurordiscare2’.</p>\n<p>50. Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease. Ending the diagnostic odyssey for children with a rare disease: Global Commission year one report 2019 [Available from: https://www.globalrarediseasecommission.com/Report/.</p>\n<p>51. Indelicato E, Nachbauer W, Eigentler A, Amprosi M, Matteucci Gothe R, Giunti P, et al. Onset features and time to diagnosis in Friedreich&#8217;s Ataxia. Orphanet J Rare Dis. 2020;15(1):198.</p>\n<p>52. Filla A, De Michele G, Coppola G, Federico A, Vita G, Toscano A, et al. Accuracy of clinical diagnostic criteria for Friedreich&#8217;s ataxia. Mov Disord. 2000;15(6):1255-8.</p>\n<p>53. Filla A, De Michele G, Cavalcanti F, Pianese L, Monticelli A, Campanella G, et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet. 1996;59(3):554-60.</p>\n<p>54. Filla A, DeMichele G, Caruso G, Marconi R, Campanella G. Genetic data and natural history of Friedreich&#8217;s disease: a study of 80 Italian patients. J Neurol. 1990;237(6):345-51.</p>\n<p>55. De Michele G, Di Maio L, Filla A, Majello M, Cocozza S, Cavalcanti F, et al. Childhood onset of Friedreich ataxia: a clinical and genetic study of 36 cases. Neuropediatrics. 1996;27(1):3-7.</p>\n<p>56. Hanna MG, Davis MB, Sweeney MG, Noursadeghi M, Ellis CJ, Elliot P, et al. Generalized chorea in two patients harboring the Friedreich&#8217;s ataxia gene trinucleotide repeat expansion. Mov Disord. 1998;13(2):339-40.</p>\n<p>57. Spacey SD, Szczygielski BI, Young SP, Hukin J, Selby K, Snutch TP. Malaysian siblings with friedreich ataxia and chorea: a novel deletion in the frataxin gene. Can J Neurol Sci. 2004;31(3):383-6.</p>\n<p>58. Zhu D, Burke C, Leslie A, Nicholson GA. Friedreich&#8217;s ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion. Mov Disord. 2002;17(3):585-9.</p>\n<p>59. Rummey C, Corben LA, Delatycki MB, Subramony SH, Bushara K, Gomez CM, et al. Psychometric properties of the Friedreich Ataxia Rating Scale. Neurology Genetics. 2019;5(6):371.</p>\n<p>60. Furman JM, Perlman S, Baloh RW. Eye movements in Friedreich&#8217;s ataxia. Arch Neurol. 1983;40(6):343-6.</p>\n<p>61. Kirkham TH, Guitton D, Katsarkas A, Kline LB, Andermann E. Oculomotor abnormalities in Friedreich&#8217;s ataxia. Can J Neurol Sci. 1979;6(2):167-72.</p>\n<p>62. Ell J, Prasher D, Rudge P. Neuro-otological abnormalities in Friedreich&#8217;s ataxia. J Neurol Neurosurg Psychiatry. 1984;47(1):26-32.</p>\n<p>63. Lamont PJ, Davis MB, Wood NW. Identification and sizing of the GAA trinucleotide repeat expansion of Friedreich&#8217;s ataxia in 56 patients. Clinical and genetic correlates. Brain. 1997;120(Pt 4):673-80.</p>\n<p>64. Konieczny MR, Senyurt H, Krauspe R. Epidemiology of adolescent idiopathic scoliosis. J Child Orthop. 2013;7(1):3-9.</p>\n<p>65. Allam AM, Schwabe AL. Neuromuscular scoliosis. PM R. 2013;5(11):957-63.</p>\n<p>66. Mary P, Servais L, Vialle R. Neuromuscular diseases: Diagnosis and management. Orthop Traumatol Surg Res. 2018;104(1S):S89-S95.</p>\n<p>67. Ahluwalia M, Ho CY. Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy. Heart. 2021;107(3):183-9.</p>\n<p>68. Stafford F, Thomson K, Butters A, Ingles J. Hypertrophic cardiomyopathy: Genetic testing and risk stratification. Curr Cardiol Rep. 2021;23(2):9.</p>\n<p>69. Berciano J, Mateo I, De Pablos C, Polo JM, Combarros O. Friedreich ataxia with minimal GAA expansion presenting as adult-onset spastic ataxia. J Neurol Sci. 2002;194(1):75-82.</p>\n<p>70. Bhidayasiri R, Perlman SL, Pulst SM, Geschwind DH. Late-onset Friedreich ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature. Arch Neurol. 2005;62(12):1865-9.</p>\n<p>71. Fearon C, Lonergan R, Ferguson D, Byrne S, Bradley D, Langan Y, et al. Very-late-onset Friedreich&#8217;s ataxia: diagnosis in a kindred with late-onset cerebellar ataxia. Pract Neurol. 2020;20(1):55-8.</p>\n<p>72. Lhatoo SD, Rao DG, Kane NM, Ormerod IE. Very late onset Friedreich&#8217;s presenting as spastic tetraparesis without ataxia or neuropathy. Neurology. 2001;56(12):1776-7.</p>\n<p>73. Lecocq C, Charles P, Azulay JP, Meissner W, Rai M, N&#8217;Guyen K, et al. Delayed-onset Friedreich&#8217;s ataxia revisited. Mov Disord. 2016;31(1):62-9.</p>\n<p>74. Schulz JB, Boesch S, Burk K, Durr A, Giunti P, Mariotti C, et al. Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol. 2009;5(4):222-34.</p>\n<p>75. Selvadurai LP, Harding IH, Corben LA, Georgiou-Karistianis N. Cerebral abnormalities in Friedreich ataxia: A review. Neurosci Biobehav Rev. 2018;84:394-406.</p>\n<p>76. Caruso G, Santoro L, Perretti A, Serlenga L, Crisci C, Ragno M, et al. Friedreich&#8217;s ataxia: electrophysiological and histological findings. Acta Neurol Scand. 1983;67(1):26-40.</p>\n<p>77. Michel C, Collins C. Pediatric neuromuscular disorders. Pediatr Clin North Am. 2020;67(1):45-57.</p>\n<p>78. Spittle AJ, FitzGerald T, Mentiplay B, Williams J, Licari M. Motor impairments in children: More than just the clumsy child. J Paediatr Child Health. 2018;54(10):1131-5.</p>\n<p>79. Mateo I, Llorca J, Volpini V, Corral J, Berciano J, Combarros O. Expanded GAA repeats and clinical variation in Friedreich&#8217;s ataxia. Acta Neurol Scand. 2004;109(1):75-8.</p>\n<p>80. Al-Mahdawi S, Ging H, Bayot A, Cavalcanti F, La Cognata V, Cavallaro S, et al. Large Interruptions of GAA Repeat Expansion Mutations in Friedreich Ataxia Are Very Rare. Front Cell Neurosci. 2018;12:443.</p>\n<p>81. Berciano J, Mateo I, De Pablos C, Polo JM, Combarros O. Friedreich ataxia with minimal GAA expansion presenting as adult-onset spastic ataxia. J Neurol Sci. 2002;194(1):75-82.</p>\n<p>82. Napierala M, Dere R, Vetcher A, Wells RD. Structure-dependent recombination hot spot activity of GAA.TTC sequences from intron 1 of the Friedreich&#8217;s ataxia gene. J Biol Chem. 2004;279(8):6444-54.</p>\n<p>83. Bit-Avragim N, Perrot A, Schols L, Hardt C, Kreuz FR, Zuhlke C, et al. The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich&#8217;s ataxia. J Mol Med. 2001;78(11):626-32.</p>\n<p>84. Isnard R, Kalotka H, Durr A, Cossee M, Schmitt M, Pousset F, et al. Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich&#8217;s ataxia. Circulation. 1997;95(9):2247-9.</p>\n<p>85. Marty B, Naeije G, Bourguignon M, Wens V, Jousmaki V, Lynch DR, et al. Evidence for genetically determined degeneration of proprioceptive tracts in Friedreich ataxia. Neurology. 2019;93(2):e116-e24.</p>\n<p>86. Monrós E, Molto MD, Martinez F, Canizares J, Blanca J, Vilchez JJ, et al. Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat. Am J Hum Genet. 1997;61(1):101-10.</p>\n<p>87. Greeley NR, Regner S, Willi S, Lynch DR. Cross-sectional analysis of glucose metabolism in Friedreich ataxia. J Neurol Sci. 2014;342(1-2):29-35.</p>\n<p>88. Cossée M, Dürr A, Schmitt M, Dahl N, Trouillas P, Allinson P, et al. Friedreich&#8217;s ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol. 1999;45(2):200-6.</p>\n<p>89. Epstein E, Farmer JM, Tsou A, Perlman S, Subramony SH, Gomez CM, et al. Health related quality of life measures in Friedreich Ataxia. J Neurol Sci. 2008;272(1-2):123-8.</p>\n<p>90. Wilson C, Fahey MC, Corben L A, Collins V, Churchyard A, Lamont PJ, et al. Quality of life in Friedreich Ataxia: what clinical, social and demographic factors are important? Eur J Neurol. 2007;14(9):1040-7.</p>\n<p>91. Xiong E, Lynch AE, Corben LA, Delatycki MB, Subramony SH, Bushara K, et al. Health related quality of life in Friedreich Ataxia in a large heterogeneous cohort. J Neurol Sci. 2020;410:116642.</p>\n<p>92. Perez-Flores J, Hernandez-Torres A, Monton F, Nieto A. Health-related quality of life and depressive symptoms in Friedreich ataxia. Qual Life Res. 2020;29(2):413-20.</p>\n<p>93. Ejaz R, Chen S, Isaacs CJ, Carnevale A, Wilson J, George K, et al. Impact of mobility device use on quality of life in children with Friedreich ataxia. J Child Neurol. 2018;33(6):397-404.</p>\n<p>94. Afsharian P, Nolan-Kenney R, Lynch AE, Balcer LJ, Lynch DR. Correlation of visual quality of life with clinical and visual status in Friedreich ataxia. J Neuroophthalmol. 2020;40(2):213-7.</p>\n<p>95. Riazi A, Cano SJ, Cooper JM, Bradley JL, Schapira AH, Hobart JC. Coordinating outcomes measurement in ataxia research: do some widely used generic rating scales tick the boxes? Mov Disord. 2006;21(9):1396-403.</p>\n<p>96. Brandsema JF, Stephens D, Hartley J, Yoon G. Intermediate-dose idebenone and quality of life in Friedreich ataxia. Pediatr Neurol. 2010;42(5):338-42.</p>\n<p>97. Paulsen EK, Friedman LS, Myers LM, Lynch DR. Health-related quality of life in children with Friedreich ataxia. Pediatr Neurol. 2010;42(5):335-7.</p>\n<p>98. Cano SJ, Riazi A, Schapira AH, Cooper JM, Hobart J. Friedreich&#8217;s ataxia impact scale: a new measure striving to provide the flexibility required by today&#8217;s studies. Mov Disord. 2009;24(7):984-2.<br />\n</div>\n<div class=\"su-tabs-pane su-u-clearfix su-u-trim\" data-title=\"&lt;strong&gt;Methodology &amp; Date&lt;/strong&gt;\">\n\n<p>These Guidelines are systematically developed evidence statements incorporating data from a comprehensive literature review of the most recent studies available (up to the Guidelines submission date) and reviewed according to the Grading of Recommendations, Assessment Development and Evaluations (GRADE) framework © The Grade Working Group.</p>\n\n\n\n<p>This chapter of the Clinical Management Guidelines for Friedreich Ataxia and the recommendations and best practice statements contained herein were endorsed by the authors and the Friedreich Ataxia Guidelines Panel in 2022.</p>\n\n\n\n<p>It is our expectation that going forward individual topics can be updated in real-time in response to new evidence versus a re-evaluation and update of all topics simultaneously.</p>\n\n</div></div></div>\n</div>\n\t\t</article>\n\n\t\t\n\t</div><!-- .main-container -->\n\n\t\n</div><!-- .page-content -->\n\n\t\t</div>\n\t\t<footer id=\"page-footer\" class=\"clear-fix\">\n<div style=\"width:100%; background-color:#FFFFFF; text-align:center; content-align:center;\">\n<br/>&nbsp;\n<hr style=\"height:2px; background-color:#BBBBBB; border:0px; margin:0px; padding:0px;\">\n<b>Partners in development of the Guidelines:</b><br/>\n<img src=\"https://frdaguidelines.org/images/fara-logo.png\" style=\"width:147px; margin:11px auto 11px auto; \" />\n<br/>&nbsp;</div>\n</footer><!-- #page-footer -->\n\t</div><!-- #page-wrap -->\n<div class=\"sgpb-main-popup-data-container-658\" style=\"position:fixed;opacity: 0;filter: opacity(0%);transform: scale(0);\">\n\t\t\t\t\t\t\t<div class=\"sg-popup-builder-content\" id=\"sg-popup-content-wrapper-658\" data-id=\"658\" data-events=\"[{&quot;param&quot;:&quot;click&quot;,&quot;operator&quot;:&quot;defaultClickClassName&quot;,&quot;value&quot;:&quot;sg-popup-id-658&quot;,&quot;hiddenOption&quot;:[]}]\" data-options=\"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\">\n\t\t\t\t\t\t\t\t<div class=\"sgpb-popup-builder-content-658 sgpb-popup-builder-content-html\"><div class=\"sgpb-main-html-content-wrapper\"><p><strong>Grading for Level of Evidence</strong></p>\n<p>The level of evidence is based on published evidence from studies in FRDA. If there is no published evidence in FRDA, evidence from other like conditions or clinical expertise may have been used to make the recommendation – this is graded as ‘very low’ or in some cases ‘low’ level evidence. See the table below for an explanation of the symbols used to grade recommendations.</p>\n<table style=\"border:0px;\">\n<tr style=\"border:0px;\">\n<td style=\"border:0px;\"><b>Level of Evidence</b></td>\n<td style=\"border:0px;\"><b>Symbol</b></td>\n</tr>\n<tr style=\"border:0px;\">\n<td style=\"border:0px;\">High</td>\n<td style=\"border:0px;\">⨁⨁⨁⨁</td>\n</tr>\n<tr style=\"border:0px;\">\n<td style=\"border:0px;\">Moderate</td>\n<td style=\"border:0px;\">⨁⨁⨁◯</td>\n</tr>\n<tr style=\"border:0px;\">\n<td style=\"border:0px;\">Low</td>\n<td style=\"border:0px;\">⨁⨁◯◯</td>\n</tr>\n<tr style=\"border:0px;\">\n<td style=\"border:0px;\">Very low</td>\n<td style=\"border:0px;\">⨁◯◯◯</td>\n</tr>\n</table>\n</div></div>\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t  </div><div class=\"sgpb-main-popup-data-container-587\" style=\"position:fixed;opacity: 0;filter: opacity(0%);transform: scale(0);\">\n\t\t\t\t\t\t\t<div class=\"sg-popup-builder-content\" id=\"sg-popup-content-wrapper-587\" data-id=\"587\" data-events=\"[{&quot;param&quot;:&quot;click&quot;,&quot;operator&quot;:&quot;defaultClickClassName&quot;,&quot;value&quot;:&quot;sg-popup-id-587&quot;,&quot;hiddenOption&quot;:[]}]\" data-options=\"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\">\n\t\t\t\t\t\t\t\t<div class=\"sgpb-popup-builder-content-587 sgpb-popup-builder-content-html\"><div class=\"sgpb-main-html-content-wrapper\"><p><strong>Grading for Strength of Recommendation</strong></p>\n<p>For the rating of the strength of the recommendation, in addition to evidence from studies in FRDA, evidence from like conditions, clinical experience and expert consensus are taken into account when published evidence is not available.</p>\n<table style=\"border:0px;\">\n<tr style=\"border:0px;\">\n<td style=\"border:0px;\"><b>Strength of Recommendation</b></td>\n<td style=\"border:0px;\"><b>Symbol</b></td>\n</tr>\n<tr style=\"border:0px;\">\n<td style=\"border:0px;\">Strong for intervention</td>\n<td style=\"border:0px;\">↑↑</td>\n</tr>\n<tr style=\"border:0px;\">\n<td style=\"border:0px;\">Conditional for intervention</td>\n<td style=\"border:0px;\">↑</td>\n</tr>\n<tr style=\"border:0px;\">\n<td style=\"border:0px;\">Neither intervention nor comparison</td>\n<td style=\"border:0px;\">—</td>\n</tr>\n<tr style=\"border:0px;\">\n<td style=\"border:0px;\">Conditional against intervention</td>\n<td style=\"border:0px;\">↓</td>\n</tr>\n<tr style=\"border:0px;\">\n<td style=\"border:0px;\">Strong against intervention</td>\n<td style=\"border:0px;\">↓↓</td>\n</tr>\n</table>\n</div></div>\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t  </div><link rel='stylesheet' id='su-shortcodes-css' href='https://frdaguidelines.org/wp-content/plugins/shortcodes-ultimate/includes/css/shortcodes.css?ver=5.12.11' type='text/css' media='all' />\n<script type=\"text/javascript\" src=\"https://frdaguidelines.org/wp-content/themes/ashe/assets/js/custom-plugins.js?ver=1.8.2\" id=\"ashe-plugins-js\"></script>\n<script type=\"text/javascript\" src=\"https://frdaguidelines.org/wp-content/themes/ashe/assets/js/custom-scripts.js?ver=1.9.7\" id=\"ashe-custom-scripts-js\"></script>\n<script type=\"text/javascript\" id=\"su-shortcodes-js-extra\">\n/* <![CDATA[ */\nvar SUShortcodesL10n = {\"noPreview\":\"This shortcode doesn't work in live preview. Please insert it into editor and preview on the site.\",\"magnificPopup\":{\"close\":\"Close (Esc)\",\"loading\":\"Loading...\",\"prev\":\"Previous (Left arrow key)\",\"next\":\"Next (Right arrow key)\",\"counter\":\"%curr% of %total%\",\"error\":\"Failed to load content. <a href=\\\"%url%\\\" target=\\\"_blank\\\"><u>Open link<\\/u><\\/a>\"}};\n/* ]]> */\n</script>\n<script type=\"text/javascript\" src=\"https://frdaguidelines.org/wp-content/plugins/shortcodes-ultimate/includes/js/shortcodes/index.js?ver=5.12.11\" id=\"su-shortcodes-js\"></script>\n</body>\n</html>\n<!-- Page generated by LiteSpeed Cache 5.4 on 2023-11-23 09:18:40 -->"